Disclosed are dendrimers of formula (I): ##STR00001##
and pharmaceutically acceptable salts thereof. Also disclosed are pharmaceutical compositions comprising the dendrimer of formula (I) and methods of using the same for treating cancer.

A method for producing a plated part, includes: forming, on a surface of a base member, a catalyst activity inhibiting layer containing a polymer which has at least one of an amide group and an amino group; irradiating with light or heating a part of the surface of the base member on which the catalyst activity inhibiting layer is formed; applying an electroless plating catalyst to the surface of the base member heated or irradiated with the light; and bringing an electroless plating solution into contact with the surface of the base member to which the electroless plating catalyst is applied, to form an electroless plating film at a light-irradiated portion or a heated portion of the surface.

The invention provides a nanomaterial of polyglycerol grafted cellulose nanocrystal dendrimer and a preparation method thereof. In the present invention, the cotton linter pulp is pulverized into flocculent fibers, fed to sulfuric acid, and reacted. After centrifugation, dialysis and ultrasonic cell disruption, cellulose nanocrystals are obtained. Carboxylated cellulose nanocrystals are further obtained after oxidation with TEMPO, dialysis, and freeze-drying. The carboxylated nanocrystals are further added to DMF, and under a nitrogen atmosphere, glycidol is grafted to the hydroxyl groups on the surface by heating with stirring. After the reaction is completed, the product is centrifuged, dried under vacuum, dialyzed, and freeze dried to obtain a nanomaterial of primary polyglycerol grafted cellulose nanocrystals. Dendrimers with different particle size ranges can be prepared by controlling the number of reactions, which contain a large number of hydroxyl groups on the surface, and are amenable to various modifications.

A conjugated cationic dendrimer comprising end groups conjugated to charge-shielding groups, wherein some charge-shielding groups are chemically linked to active pharmaceutical ingredients.

This disclosure relates to polymers and polymer compositions having monomer units of polyoxometalates and monomer units comprising hydroxy-terminated molecules such as branched molecules or dendrimers and uses in degradation, decontamination, and deodorization. In certain embodiments, the hydroxy-terminated branched molecules or dendrimers comprise terminal 1,1-tris(hydroxymethyl)methyl or 1,1,1-tris(hydroxyalkyl)methyl groups. In certain embodiments, the hydroxy-terminated molecule is N,N′,N″-tris[tris(hydroxymethyl) methyl]-1,3,5-benzenetricarboxamide.

Polymer composition comprising (a) 33 to 52 wt.-% star-shaped block copolymers (a) comprising terminal vinylaromatic polymer blocks S.sub.1 and S.sub.2, and random styrene/butadiene copolymer blocks (B/S); and (b) 48 to 67 wt.-% SMMA copolymers (b). Moldings and shaped articles produced thereof have a high clarity and toughness and can be used in the household, appliance and healthcare sector.

The present invention provides a cyanine modified telodendrimer, nanoparticles thereof, and methods of using the nanoparticles to treat various diseases such as cancer.

A polymer composition comprising star macromolecules is provided. Each star macromolecule has a core and five or more arms, wherein the number of arms within a star macromolecule varies across the composition of star molecules. The arms on a star are covalently attached to the core of the star; each arm comprises one or more (co)polymer segments; and at least one arm and/or at least one segment exhibits a different solubility from at least one other arm or one other segment, respectively, in a reference liquid of interest.

The present invention relates to a targeting-type capsule for drug delivery systems. The present invention addresses the problem of providing a capsule for drug delivery systems by utilizing the reactivity of a thiol with an alkyl halide, wherein the capsule comprises a silole-containing carbosilane dendrimer and a labeling protein containing a target recognition site (e.g., green fluorescent protein), can include a biological polymer or another molecule therein, and can deliver the biological polymer or the like selectively into a target cell.

A fabrication method and application of topological elastomers with highly branched structures, low modulus and high elasticity. The topological elastomers comprise dendritic macromolecules. The fabrication method includes direct crosslinking, post-crosslinking, grafting, and copolymerization. The performance of the elastomer can be easily tuned via changing the topology of the polymer network. The breakthrough of this invention lies in that these topological elastomers with highly branched structures are having low modulus and high elasticity, which would expand its application in the field of elastomer. Notably, the variety of topological elastomers, the versatility of curing chemistries, the availability of a wide variety of monomers, and the various polymerization methods are enabling the fabrication of topological elastomers with feasibility and efficiency.